Roberto Pazo-Cid
ASCO 2021 Solid Tumors - Roberto Pazo-Cid Roberto
ASCO 2021 Solid Tumors - Roberto Pazo-Cid Roberto
多种实体瘤中的新型组合方法 乐伐替尼(lenvatinib)加派姆单抗 抗血管生成多激酶
卵巢癌:将PARP抑制更进一步 尼拉帕利(niraparib)的个性化用量 根据NOVA
将创新从实验室带入临床实践 Andrés Cervantes, MD, PhD, 西班牙
胃癌和食管癌中PD-1抑制取得的里程碑式进展 胃癌、胃食管连接部(GEJ)腺癌和食道腺癌
Novel combination approaches in various solid tu
Ovarian cancer: taking PARP inhibition one step
Getting innovation from the laboratories into cl
Milestones of PD-1 inhibition in gastric and eso
Preface – ESMO 2020 Solid Tumors Ronan Kel